ESTRO 2024 - Abstract Book

S3730

Physics - Dose prediction, optimisation and applications of photon and electron planning

ESTRO 2024

Conclusion:

DTRT had higher absolute MSAQ scores, but was non-inferior to ncVMAT in terms of motion sickness in healthy volunteers undergoing repeat dry-runs of both treatments, and overall rates of clinically relevant motion sickness were low (0.6%).

Supported by Varian, a Siemens Healthineers Company.

Keywords: new techniques, phase I, clinical trial

References:

1) Gianaros PJ, Muth ER, Mordkoff JT, Levine ME, Stern RM. A questionnaire for the assessment of the multiple dimensions of motion sickness. Aviation, space, and environmental medicine. 2001 Feb;72(2):115.

3119

Digital Poster

Large bicentric study on dosimetric changes during head and neck radiotherapy

Cristian Candela-Juan 1 , Fernando Pérez 2 , Izaskun Valduvieco 1 , Jon Cacicedo 3 , Artur Latorre-Musoll 1 , Jordi Sáez 1 , Meritxell Mollà 1 1 Hospital Clínic Barcelona, Radiation Oncology Department, Barcelona, Spain. 2 Hospital Universitario de Cruces, Department of Radiation Protection and Medical Physics, Barakaldo, Spain. 3 Hospital Universitario de Cruces, Radiation Oncology Department, Barakaldo, Spain

Purpose/Objective: